Despite advances in treatment, lung cancer has been steadily increasing world-wide over the last several decades and remains the leading cause of cancer-related death. While research continues to produce encouraging developments in the treatment of lung cancer, prevention and early detection offers the most effective way to reduce death from lung cancer. This ICAPS conference will provide the collaborative atmosphere and educational framework to advance lung cancer prevention science, and will focus on the following principal topics and current challenges:
- Current status of lung cancer prevention clinical trials
- Lung cancer risk assessment
- Advances in molecular screening for lung cancer
- Current status of tobacco control policies
Objectives of the 2016 ICAPS Conference:
To promote communication between cancer prevention researchers and clinicians and to advance lung cancer prevention research. We will:
- Review current cancer prevention and early detection strategies for lung cancer.
- Facilitate interaction among scientists, and early cancer prevention scientists to interact with senior leaders in this field present at the iCAPS meeting and the World Congress.These interactions will stimulate research collaborations, and will stimulate research propelling the field of cancer prevention forward.
- Evaluate current evidence relating to lung cancer prevention, and produce consensus recommendations for future lung cancer prevention clinical trials.
Distinctive features of this year’s program include:
- Exploration of potential vaccine strategies that target the nicotine receptor for lung cancer prevention
- Examination of novel chemotherapy strategies that show high potential for being effective in preventing lung cancer
- Organization of the meeting to be held in conjunction with the large-scale 17th World Conference on Lung Cancer (WCLC) to maximize attendance and opportunities for collaboration